Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 4Pancreatic Neoplasms 3Lung Neoplasms 2Liver Neoplasms 2Agnosia 2Uterine Cervical Neoplasms 1Thoracic Neuritis 1Stomach Neoplasms 1Reperfusion Injury 1Prostatic Neoplasms 1Neoplasms 1Leiomyoma 1Inflammation 1Endometrial Neoplasms 1End Stage Liver Disease 1Colonic Neoplasms 1Breast Neoplasms 1Breast Cancer Female 1Bites and Stings 1Biliary Tract Neoplasms 1Adenomyosis 1Acute Pain 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Analgesia, Patient-Controlled × Clear all
NCT03580980 2018-07-10

Multimodal Analgesia in Major Abdominal Pediatric Cancer Surgeries

National Cancer Institute, Egypt

Phase NA Completed
90 enrolled

Neoplasms, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡